Search

everythinglearnresearchcommunity

for

Search:↓

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Targeting ornithine decarboxylase can help prevent skin cancer.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

A man developed alopecia areata after starting cancer treatment with vandetanib.

The new Brigatinib nanocarrier is more effective against lung cancer cells than the free drug.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

A3B5 can reduce skin pigmentation and slow melanoma growth.

Selumetinib significantly reduced tumor size and improved vision in a child with neurofibromatosis type 1.

Targeting the Smoothened receptor shows promise for treating certain cancers.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Nilotinib can cause skin issues like red bumps and hair loss.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Photodynamic therapy improved skin issues from sorafenib when other treatments failed.

High MUC-18/MCAM levels in blood indicate a worse outlook for melanoma patients.